Company / SG&A per Share
InMed Pharmaceuticals Inc. SG&A per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$13.00
FY2025
5-year range
$1.76 / $13.91
FY2022-FY2025
Trend
+640.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +640% YoY in FY2025, a notable deviation from the 3-year average annual change of +178%.
Based on SEC 10-K filings.
13.00 in FY2025 with a 3-year CAGR of -2.2%.
Increased from $10.55 to $13.00 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 640.1% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.00 | +640.1% |
| FY2024 | $1.76 | -83.4% |
| FY2023 | $10.55 | -24.1% |
| FY2022 | $13.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026